Targeting Inflammatory Cytokines to Improve Type 2 Diabetes Control
Type 2 diabetes (T2D) is one of the most common chronic metabolic disorders in adulthood worldwide, whose pathophysiology includes an abnormal immune response accompanied by cytokine dysregulation and inflammation. As the T2D-related inflammation and its progression were associated with the balance...
Main Authors: | Tsvetelina V. Velikova, Plamena P. Kabakchieva, Yavor S. Assyov, Tsvetoslav А. Georgiev |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2021/7297419 |
Similar Items
-
Serum levels of matrix metalloproteinase-3 as a prognostic marker for progression of cartilage injury in patients with knee osteoarthritis
by: Tsvetoslav Georgiev, et al.
Published: (2020-07-01) -
Prevalence of Positive Diabetes-Associated Autoantibodies among Type 2 Diabetes and Related Metabolic and Inflammatory Differences in a Sample of the Bulgarian Population
by: Emanuela Tsvetkova Zaharieva, et al.
Published: (2017-01-01) -
Laboratory Assessment of Disease Activity in Pediatric Patients with Inflammatory Bowel Disease: What’s New?
by: Rayna Shentova-Eneva, et al.
Published: (2020-12-01) -
Clinical characteristics and disability in patients with knee osteoarthritis: real world experience from Bulgaria
by: Tsvetoslav Georgiev
Published: (2019-04-01) -
Evaluation of pro-inflammatory and anti-inflammatory cytokines in type 1 diabetes mellitus
by: Weaam Gouda, et al.
Published: (2018-10-01)